COVID-19, cytokines, inflammation, and spices: How are they related?

AB Kunnumakkara, V Rana, D Parama, K Banik… - Life sciences, 2021 - Elsevier
Background Cytokine storm is the exaggerated immune response often observed in viral
infections. It is also intimately linked with the progression of COVID-19 disease as well as …

Vaccination and immunotherapies in neuroimmunological diseases

A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

Experience in multiple sclerosis patients with COVID-19 and disease-modifying therapies: a review of 873 published cases

N Möhn, FF Konen, R Pul, C Kleinschnitz… - Journal of clinical …, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a
challenge for all participants in the healthcare system. At the beginning of the pandemic …

The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study

N Ziadé, I Hmamouchi, L El Kibbi, N Abdulateef… - Clinical …, 2020 - Springer
Objective To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on
rheumatology practice. Method A cross-sectional web survey was designed by the members …

Impact of the COVID‐19 pandemic on patients with chronic rheumatic diseases: a study in 15 Arab countries

N Ziade, L El Kibbi, I Hmamouchi… - … journal of rheumatic …, 2020 - Wiley Online Library
Aim To evaluate the impact of the coronavirus disease 2019 pandemic (COVID‐19) on the
access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab …

Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic

H Alnajashi, R Jabbad - PLoS One, 2020 - journals.plos.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in late 2019 and Covid-19, a disease caused by SARS-CoV-2 became a pandemic in March …

SARS-CoV-2 infection in multiple sclerosis: results of the Spanish Neurology Society Registry

G Arrambide, MÁ Llaneza-González… - Neurology …, 2021 - AAN Enterprises
Objective To understand COVID-19 characteristics in people with multiple sclerosis (MS)
and identify high-risk individuals due to their immunocompromised state resulting from the …

Repurposing of sitagliptin-melittin optimized nanoformula against SARS-CoV-2; antiviral screening and molecular docking studies

MW Al-Rabia, NA Alhakamy, OAA Ahmed, K Eljaaly… - Pharmaceutics, 2021 - mdpi.com
The outbreak of the COVID-19 pandemic in China has become an urgent health and
economic challenge. The objective of the current work was to evaluate the efficacy of the …

Multiple sclerosis patients and disease modifying therapies: impact on immune responses against COVID-19 and SARS-CoV-2 vaccination

M Golshani, J Hrdý - Vaccines, 2022 - mdpi.com
This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS).
The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 …

Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic

L Dumitrescu, A Papathanasiou… - … Journal of Medicine, 2021 - academic.oup.com
Beta interferons (IFN-β) are pleiotropic cytokines with antiviral properties. They play
important roles in the pathogenesis of multiple sclerosis (MS), an incurable immune …